Trials / Completed
CompletedNCT06608498
DMHI for At-Risk College Students
User-Centered Design of a Single-Module Digital Mental Health Intervention for College Students at Risk for Psychosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- University of Washington · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn if a single-session digital intervention (SPARK Coping) is acceptable, usable, and demonstrates a preliminary signal of efficacy in reducing symptom-related distress and increasing positive treatment-seeking attitudes among college students reporting subthreshold symptoms associated with risk for psychosis. Research questions inclue: * Does SPARK Coping reduce symptom-related distress and increase positive treatment seeking attitudes (primary outcomes) relative to a waitlist control condition? * Does SPARK Coping increase adaptive coping and reduce internalized stigma (primary targets) relative to a waitlist control condition? Researchers will compare provision of SPARK Coping to a waitlist control condition and collect data from participants on each of the variables described above. Participants will: * Complete questionnaires and surveys remotely at the start of the study and two weeks later * Be offered access to the SPARK Coping intervention either after completion of their baseline assessment (intervention arm) or after two weeks (waitlist control arm).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | SPARK Coping | SPARK Coping is a single-session intervention providing psychoeducation and structured practices related to stigma reduction, cognitive restructuring, behavioral activation, and effective coping. It is a self-guided website powered by research data capture software. |
Timeline
- Start date
- 2024-10-04
- Primary completion
- 2025-01-06
- Completion
- 2025-01-06
- First posted
- 2024-09-23
- Last updated
- 2025-12-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06608498. Inclusion in this directory is not an endorsement.